Another gap in our knowledge involves TRFT’s modulation of VEGF in the context of brain cancers in that some clinical studies have utilized anti-VEGF agents in an attempt to limit brain tumor vascularization [69], suggesting that increasing VEGF levels may encourage brain cancer growth. Here, VEGFA is linked to brain cancer.